Professor Riccardo Lencioni, MD, FSIR, EBIR, is the Director of the Division of Diagnostic Imaging and Intervention at Pisa University School of Medicine in Pisa, Italy. He is board certified in Radiology and Gastroenterology.

Professor Lencioni is one of the world’s foremost interventional oncology specialists, known especially for his highly influential work in liver cancer. He has been a leading member of several expert panels developing recommendations for research and clinical management of hepatocellular carcinoma. He has co-authored the white papers Design and Endpoints in Clinical Trials in Hepatocellular Carcinoma (2008), Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma (2010), and EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma (2012).

Riccardo Lencioni is the Chairman of the Board of the World Conference on Interventional Oncology. He is also a Board Member of the European Conference on Interventional Oncology and a co-Founder of the International Liver Cancer Association, in which he currently acts as the Executive Secretary.

Professor Lencioni is an Associate Editor of Liver Cancer and serves as an editorial board member or reviewer for several other journals, including the leading titles in Oncology, Hepatology, and Interventional Radiology.

Riccardo Lencioni has published 180 articles in peer-reviewed international journals indexed in PubMed and numerous chapters in textbooks of interventional radiology, gastroenterology, oncology and surgery. In addition, he has been the editor of seven books. According to the SCOPUS database, citations of his publications currently number in excess of 12,000 with an h index of 48. Riccardo Lencioni has been an invited or honorary lecturer at more than 450 international meetings or conferences.